Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Nov-09 3:42 PM View:  | Gluskin Anna E CEO & Pres. Director | Generex Biotechnology Corp. (GNBT) | 16-Nov-19 | Purchase | 10,000 | $0.51 | $5,100.00 | < 1% 1.17M to 1.18M | 2% |
| 16-Feb-16 10:00 PM View: | Brusegard David Chief Operating Officer | Generex Biotechnology Corp. (GNBT) | 16-Feb-16 | Option Exercise | 1,667,670 | $0.00 | $1,667.67 | 42% 3.95M to 5.62M | |
| 16-Feb-16 10:00 PM View: | Fletcher Mark President & CEO Director | Generex Biotechnology Corp. (GNBT) | 16-Feb-16 | Option Exercise | 4,447,110 | $0.00 | $4,447.11 | 39% 11.37M to 15.82M | |
| 27-Apr-15 4:00 PM View: | Barratt John P Director | Generex Biotechnology Corp. (GNBT) | 27-Apr-15 | Option Exercise | 5,874,160 | $0.00 | $5,874.16 | 100% 0 to 5.87M | |
| 08-Oct-14 3:31 PM View: | Barratt John P Director | Generex Biotechnology Corp. (GNBT) | 06-Oct-14 | Option Exercise | 35,714 | $0.00 | $35.71 | 100% 0 to 35.71K | |
| 08-Oct-14 3:38 PM View: | Fletcher Mark President & CEO Director | Generex Biotechnology Corp. (GNBT) | 06-Oct-14 | Option Exercise | 470,726 | $0.00 | $470.73 | 100% 0 to 470.73K | |
| 08-Oct-14 3:26 PM View: | McGee Brian Director | Generex Biotechnology Corp. (GNBT) | 06-Oct-14 | Option Exercise | 35,714 | $0.00 | $35.71 | 100% 0 to 35.71K | |
| 20-Jun-13 4:00 PM View: | Fellows Stephen CHIEF FINANCIAL OFFICER | Generex Biotechnology Corp. (GNBT) | 18-Jun-13 | Sale | 2,524,160 | $0.04 | $89,607.80 | (100%) 2.52M to 0 | |
| 10-Jun-13 4:35 PM View: | Fellows Stephen CHIEF FINANCIAL OFFICER | Generex Biotechnology Corp. (GNBT) | 06-Jun-13 | Option Exercise | 2,524,160 | $0.00 | $2,524.16 | 100% 0 to 2.52M | |
| 05-Jul-12 4:34 PM View: | Masterson Nola E Director | Generex Biotechnology Corp. (GNBT) | 03-Jul-12 | Option Exercise | 508,197 | $0.00 | $508.20 | 100% 0 to 508.2K | |
| 27-Jun-12 4:09 PM View: | Fellows Stephen Acting Chief Financial Officer | Generex Biotechnology Corp. (GNBT) | 25-Jun-12 | Market Sale | 546,448 | $0.09 | $50,382.50 | (100%) 546.45K to 0 | 74% |
| 21-Jun-12 7:19 PM View: | Fellows Stephen Acting Chief Financial Officer | Generex Biotechnology Corp. (GNBT) | 21-Jun-12 | Option Exercise | 546,448 | $0.00 | $546.45 | 100% 0 to 546.45K | |
| 11-May-11 10:35 AM View: | Perri Rose C Director | Generex Biotechnology Corp. (GNBT) | 09-May-11 | Market Sale | 15,000 | $0.23 | $3,450.00 | (< 1%) 3.74M to 3.72M | 86% |
| 09-May-11 5:01 PM View: | Perri Rose C Director | Generex Biotechnology Corp. (GNBT) | 06-May-11 | Market Sale | 20,000 | $0.22 | $4,500.00 | (< 1%) 3.76M to 3.74M | 86% |
| 04-May-11 9:51 PM View: | Perri Rose C Director | Generex Biotechnology Corp. (GNBT) | 03-May-11 | Market Sale | 25,000 | $0.22 | $5,500.00 | (< 1%) 3.78M to 3.76M | 86% |
| 07-Apr-11 9:58 AM View: | Fletcher Mark See Remarks | Generex Biotechnology Corp. (GNBT) | 06-Apr-11 | Market Purchase | 20,000 | $0.24 | $4,780.00 | 8% 266.08K to 286.08K | (87%) |
| 03-Jan-11 5:18 PM View: | Perri Rose C COO, CFO& Treas. Director | Generex Biotechnology Corp. (GNBT) | 03-Jan-11 | Option Exercise | 576,752 | $0.00 | $576.75 | 18% 3.21M to 3.78M | |
| 27-Oct-10 4:01 PM View: | Perri Rose C COO, CFO& Treas. Director | Generex Biotechnology Corp. (GNBT) | 27-Oct-10 | Market Purchase | 54,000 | $0.35 | $18,900.00 | 2% 3.15M to 3.21M | (93%) |
| 04-Jan-10 12:48 PM View: | Fletcher Mark EVP & General Counsel | Generex Biotechnology Corp. (GNBT) | 04-Jan-10 | Market Purchase | 8,700 | $0.52 | $4,524.00 | 3% 257.38K to 266.08K | (95%) |
| 16-Nov-09 3:42 PM View: | Perri Rose C COO, CFO, Treas. & Secy. Director | Generex Biotechnology Corp. (GNBT) | 16-Nov-09 | Market Purchase | 10,000 | $0.51 | $5,100.00 | < 1% 3.14M to 3.15M | (95%) |
| 16-Nov-09 2:32 PM View: | Masterson Nola E Director | Generex Biotechnology Corp. (GNBT) | 13-Nov-09 | Market Purchase | 10,000 | $0.49 | $4,900.00 | 20% 50.0K to 60.0K | (95%) |
| 16-Nov-09 2:37 PM View: | Fletcher Mark EVP & General Counsel | Generex Biotechnology Corp. (GNBT) | 13-Nov-09 | Market Purchase | 10,000 | $0.49 | $4,900.00 | 4% 247.38K to 257.38K | (95%) |
| 13-Nov-09 4:06 PM View: | Masterson Nola E Director | Generex Biotechnology Corp. (GNBT) | 12-Nov-09 | Market Sale | 50,000 | $0.50 | $25,000.00 | (50%) 100.0K to 50.0K | 95% |
| 19-Oct-09 5:09 PM View: | Masterson Nola E Director | Generex Biotechnology Corp. (GNBT) | 19-Oct-09 | Market Sale | 2,700 | $0.69 | $1,863.00 | (3%) 102.7K to 100.0K | 96% |
| 12-Jan-09 5:31 PM View: | Fletcher Mark EVP & General Counsel | Generex Biotechnology Corp. (GNBT) | 12-Jan-09 | Market Purchase | 12,359 | $0.32 | $3,976.88 | 5% 235.02K to 247.38K | (93%) |
| 03-Nov-08 10:33 AM View: | Fletcher Mark EVP & General Counsel | Generex Biotechnology Corp. (GNBT) | 31-Oct-08 | Market Purchase | 25,000 | $0.38 | $9,495.00 | 12% 210.02K to 235.02K | (94%) |
| 14-Oct-08 11:43 AM View: | Perri Rose C COO, CFO, Treas. & Secy. Director | Generex Biotechnology Corp. (GNBT) | 13-Oct-08 | Market Purchase | 15,000 | $0.30 | $4,538.00 | < 1% 3.13M to 3.14M | (93%) |
| 21-Apr-08 4:57 PM View: | Fletcher Mark VP & General Counsel | Generex Biotechnology Corp. (GNBT) | 18-Apr-08 | Market Option Sale | 228,342 | $1.15 | $262,877.00 | (52%) 438.36K to 210.02K | 98% |
| 21-Apr-08 4:57 PM View: | Fletcher Mark VP & General Counsel | Generex Biotechnology Corp. (GNBT) | 18-Apr-08 | Option Exercise | 250,000 | $0.89 | $222,500.00 | 133% 188.36K to 438.36K | 16% |
| 09-Apr-08 5:04 PM View: | Bernstein Gerald VP, Medical Affairs Director | Generex Biotechnology Corp. (GNBT) | 08-Apr-08 | Option Exercise | 50,000 | $1.00 | $50,000.00 | 1441% 3.47K to 53.47K | (98%) |
| 12-Mar-08 12:05 PM View: | Masterson Nola E Director | Generex Biotechnology Corp. (GNBT) | 11-Mar-08 | Market Purchase | 2,700 | $1.06 | $2,862.00 | 3% 100.0K to 102.7K | (98%) |
| 28-Feb-08 8:13 PM View: | Barratt John P Director | Generex Biotechnology Corp. (GNBT) | 27-Feb-08 | Option Exercise | 70,000 | $1.00 | $70,000.00 | 16% 425.71K to 495.71K | |
| 21-Aug-07 7:27 PM View: | Fletcher Mark Exec. VP & General Counsel | Generex Biotechnology Corp. (GNBT) | 17-Aug-07 | Grant | 175,000 | -- | -- | 1310% 13.36K to 188.36K | |
| 30-Aug-07 5:37 PM View: | Masterson Nola E Director | Generex Biotechnology Corp. (GNBT) | 17-Aug-07 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 21-Aug-07 7:24 PM View: | Gluskin Anna E President & CEO Director | Generex Biotechnology Corp. (GNBT) | 17-Aug-07 | Grant | 200,000 | -- | -- | 21% 969.79K to 1.17M | |
| 21-Aug-07 7:25 PM View: | Perri Rose C COO, CFO, Sec., Treasurer Director | Generex Biotechnology Corp. (GNBT) | 17-Aug-07 | Grant | 175,000 | -- | -- | 4% 4.1M to 4.28M | |
| 01-Jun-06 1:33 PM View: | Allport Settle Mindy J Director | Generex Biotechnology Corp. (GNBT) | 30-May-06 | Grant | 150,000 | -- | -- | 4839% 3.1K to 153.1K | |
| 01-Jun-06 1:34 PM View: | McGee Brian Director | Generex Biotechnology Corp. (GNBT) | 30-May-06 | Grant | 150,000 | -- | -- | 150% 100.0K to 250.0K | |
| 01-Jun-06 1:32 PM View: | Barratt John P Director | Generex Biotechnology Corp. (GNBT) | 30-May-06 | Grant | 150,000 | -- | -- | 100% 0 to 150.0K | |
| 01-Jun-06 1:31 PM View: | Amanatides Peter Director | Generex Biotechnology Corp. (GNBT) | 30-May-06 | Grant | 150,000 | -- | -- | 15000% 1.0K to 151.0K | |
| 28-Mar-06 10:23 AM View: | McGee Brian Director | Generex Biotechnology Corp. (GNBT) | 27-Mar-06 | Market Purchase | 26,000 | $3.22 | $83,720.00 | 35% 74.0K to 100.0K | (99%) |
| 28-Mar-06 10:23 AM View: | McGee Brian Director | Generex Biotechnology Corp. (GNBT) | 27-Mar-06 | Grant | 4,000 | $3.02 | $12,080.00 | 6% 70.0K to 74.0K | (99%) |
| 22-Mar-06 11:33 AM View: | Allport Settle Mindy J Director | Generex Biotechnology Corp. (GNBT) | 20-Mar-06 | Market Purchase | 3,100 | $3.19 | $9,889.00 | 100% 0 to 3.1K | (99%) |
| 02-Mar-06 4:42 PM View: | McGee Brian Director | Generex Biotechnology Corp. (GNBT) | 28-Feb-06 | Market Purchase | 70,000 | $2.21 | $154,700.00 | 100% 0 to 70.0K | (99%) |
| 15-Apr-05 4:26 PM View: | Amanatides Peter Director | Generex Biotechnology Corp. (GNBT) | 05-Aug-05 | Purchase | 1,000 | $0.78 | $780.00 | 100% 0 to 1.0K | |
| 23-Jan-04 10:00 PM View: | Gluskin Anna E CEO and President Director | Generex Biotechnology Corp. (GNBT) | 23-Jan-04 | Market Purchase | 500 | $1.71 | $855.00 | < 1% 969.67K to 970.17K | (99%) |
| 23-Jan-04 10:00 PM View: | Perri Rose C COO, Acting CFO, Secretary Director 10% Owner | Generex Biotechnology Corp. (GNBT) | 23-Jan-04 | Market Purchase | 500 | $1.71 | $855.00 | < 1% 3.15M to 3.15M | (99%) |
| 03-Dec-03 10:00 PM View: | Perri Rose C COO, Acting CFO, Secretary Director 10% Owner | Generex Biotechnology Corp. (GNBT) | 01-Dec-03 | Market Purchase | 100 | $1.56 | $156.00 | < 1% 3.15M to 3.15M | (99%) |
| 03-Dec-03 10:00 PM View: | Gluskin Anna E CEO and President Director | Generex Biotechnology Corp. (GNBT) | 01-Dec-03 | Market Purchase | 500 | $1.56 | $780.00 | < 1% 969.67K to 970.17K | (99%) |
| 25-Nov-03 10:00 PM View: | Perri Rose C COO, Acting CFO, Secretary Director 10% Owner | Generex Biotechnology Corp. (GNBT) | 24-Nov-03 | Market Purchase | 500 | $1.61 | $807.00 | < 1% 3.15M to 3.15M | (99%) |
